In the swim of things: Recent insights to neurogenetic disorders from zebrafish

Trends in Genetics

Volumn 26, Issue 8, 2010, Pages 373-381

  Kabashi, Edor ^a,b   Champagne, Nathalie ^a,b   Brustein, Edna ^b   Drapeau, Pierre ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN 1; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; DEVELOPMENTAL DISORDER; ENTEROPATHY; GENETIC ANALYSIS; HEARING IMPAIRMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; ICHTHYOSIS; KERATODERMA; MENTAL RETARDATION MALFORMATION SYNDROME; MISSENSE MUTATION; MOTOR NEURON DISEASE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SCHIZOPHRENIA; SPINAL MUSCULAR ATROPHY; ZEBRA FISH;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; HUMANS; MUTATION; NEURODEGENERATIVE DISEASES; SWIMMING; ZEBRAFISH;

DANIO RERIO;

EID: 77955089579     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2010.05.004     Document Type: Review

References (75)

1. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr. Dis. Treat. 2008, 4:567-576.
2. Ingham P.W. The power of the zebrafish for disease analysis. Hum. Mol. Genet. 2009, 18:R107-112.
3. Leimer U., et al. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 1999, 38:13602-13609.
4. Joshi P., et al. Amyloid precursor protein is required for convergent-extension movements during Zebrafish development. Dev. Biol. 2009, 335:1-11.
5. Diekmann H., et al. Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J. Neurosci. 2009, 29:1343-1349.
6. Carrel T.L., et al. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 2006, 26:11014-11022.
7. Oprea G.E., et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008, 320:524-527.
8. Montpetit A., et al. Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet. 2008, 4:e1000296.
9. Drapeau P., et al. Development of the locomotor network in zebrafish. Prog. Neurobiol. 2002, 68:85-111.
10. Lemmens R., et al. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 2007, 16:2359-2365.
11. Gros-Louis F., et al. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2006, 1762:956-972.
12. Gros-Louis F., et al. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum. Mol. Genet. 2008, 17:2691-2702.
13. Hadano S., et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet. 2006, 15:233-250.
14. Simpson C.L., et al. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum. Mol. Genet. 2009, 18:472-481.
15. Kabashi E., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
16. Sreedharan J., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
17. Neumann M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
18. Kabashi E., et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2010, 19:671-683.
19. Salinas S., et al. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008, 7:1127-1138.
20. Valdmanis P.N., et al. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am. J. Hum. Genet. 2007, 80:152-161.
21. Lin P., et al. A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am. J. Hum. Genet. 2008, 83:752-759.
22. Wood J.D., et al. The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo. Hum. Mol. Genet. 2006, 15:2763-2771.
23. Tarrade A., et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum. Mol. Genet. 2006, 15:3544-3558.
24. McWhorter M.L., et al. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 2003, 162:919-931.
25. Workman E., et al. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. Hum. Mol. Genet. 2009, 18:2215-2229.
26. Boon K.L., et al. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 2009, 18:3615-3625.
27. Wood J.D., et al. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum. Mol. Genet. 2009, 18:391-404.
28. Elsen G.E., et al. The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration. Dev. Biol. 2009, 335:78-92.
29. Gauthier J., et al. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:421-424.
30. Roussignol G., et al. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 2005, 25:3560-3570.
31. Gauthier, J. et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 107, 7863-7868.
32. Setou M., et al. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 2000, 288:1796-1802.
33. Insinna C., et al. The homodimeric kinesin, Kif17, is essential for vertebrate photoreceptor sensory outer segment development. Dev. Biol. 2008, 316:160-170.
34. Tarabeux, J. et al. De Novo Truncating Mutation in Kinesin 17 Associated with Schizophrenia. Biol. Psychiatry, doi:10.1016/j.biopsych.2010.04.018.
35. Bonifacino J.S., Glick B.S. The mechanisms of vesicle budding and fusion. Cell 2004, 116:153-166.
36. Bretaud S., et al. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 2007, 100:1626-1635.
37. Schiffer N.W., et al. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J. Biol. Chem. 2007, 282:9195-9203.
38. Sipe C.W., Saha M.S. The use of microarray technology in nonmammalian vertebrate systems. Methods Mol. Biol. 2007, 382:1-16.
39. Hegde A., et al. Genomewide expression analysis in zebrafish mind bomb alleles with pancreas defects of different severity identifies putative Notch responsive genes. PLoS One 2008, 3:e1479.
40. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
41. Yeh J.R., et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat. Chem. Biol. 2009, 5:236-243.
42. Mukhopadhyay A., Peterson R.T. Deciphering arterial identity through gene expression, genetics, and chemical biology. Curr. Opin. Hematol. 2008, 15:221-227.
43. Kokel D., Peterson R.T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct. Genomic. Proteomic. 2008, 7:483-490.
44. Rihel J., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
45. Williams A., et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
46. Paquet D., et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 2009, 119:1382-1395.
47. Boehmler W., et al. Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr. Patterns 2009, 9:144-151.
48. Wen L., et al. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314:84-92.
49. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 2000, 26:216-220.
50. Suster M.L., et al. Transgenesis in zebrafish with the tol2 transposon system. Methods. Mol. Biol. 2009, 561:41-63.
51. Goldman D., et al. Transgenic zebrafish for studying nervous system development and regeneration. Transgenic Res. 2001, 10:21-33.
52. Tomasiewicz H.G., et al. Transgenic zebrafish model of neurodegeneration. J. Neurosci. Res. 2002, 70:734-745.
53. Jessell T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 2000, 1:20-29.
54. Nakano T., et al. Identification of a conserved 125 base-pair Hb9 enhancer that specifies gene expression to spinal motor neurons. Dev. Biol. 2005, 283:474-485.
55. Higashijima S., et al. Visualization of cranial motor neurons in live transgenic zebrafish expressing green fluorescent protein under the control of the islet-1 promoter/enhancer. J. Neurosci. 2000, 20:206-218.
56. Suster M.L., et al. A novel conserved evx1 enhancer links spinal interneuron morphology and cis-regulation from fish to mammals. Dev. Biol. 2009, 325:422-433.
57. Picker A., et al. A novel positive transcriptional feedback loop in midbrain-hindbrain boundary development is revealed through analysis of the zebrafish pax2.1 promoter in transgenic lines. Development 2002, 129:3227-3239.
58. McLean D.L., et al. A topographic map of recruitment in spinal cord. Nature 2007, 446:71-75.
59. Kimura Y., et al. alx, a zebrafish homolog of Chx10, marks ipsilateral descending excitatory interneurons that participate in the regulation of spinal locomotor circuits. J. Neurosci. 2006, 26:5684-5697.
60. Blader P., et al. Multiple regulatory elements with spatially and temporally distinct activities control neurogenin1 expression in primary neurons of the zebrafish embryo. Mech. Dev. 2003, 120:211-218.
61. Ng A.N., et al. Formation of the digestive system in zebrafish. III. Intestinal epithelium morphogenesis. Dev. Biol. 2005, 286:114-135.
62. Shin J., et al. Neural cell fate analysis in zebrafish using olig2 BAC transgenics. Methods Cell Sci. 2003, 25:7-14.
63. Kirby B.B., et al. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat. Neurosci. 2006, 9:1506-1511.
64. Suster M.L., et al. Transposon-mediated BAC transgenesis in zebrafish and mice. BMC Genomics 2009, 10:477.
65. Bayer T.A., Campos-Ortega J.A. A transgene containing lacZ is expressed in primary sensory neurons in zebrafish. Development 1992, 115:421-426.
66. Halpern M.E., et al. Gal4/UAS transgenic tools and their application to zebrafish. Zebrafish 2008, 5:97-110.
67. Dong J., Stuart G.W. Transgene manipulation in zebrafish by using recombinases. Methods Cell Biol. 2004, 77:363-379.
68. Moens C.B., et al. Reverse genetics in zebrafish by TILLING. Brief Funct. Genomic. Proteomic. 2008, 7:454-459.
69. Foley J.E., et al. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One 2009, 4:e4348.
70. Nornes S., et al. Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. Exp Cell Res 2003, 289:124-132.
71. Campbell W.A., et al. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J Neurochem 2006, 96:1423-1440.
72. Anichtchik O., et al. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 2008, 28:8199-8207.
73. Son O.L., et al. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Biochem Biophys Res Commun 2003, 312:601-607.
74. Flinn L., et al. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
75. Drerup C.M., et al. Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation. Development 2009, 136:2623-2632.